1-4 of 4
Andrew S. Kraft, MD
Close
Sort by
Journal Articles

Therapeutic Targeting of PIM Protein Kinases in a Subset of T-Cell Acute Lymphoblastic Leukemia

Sathish Kumar Reddy Padi, PhD, Libia A Luevano, ND, Ningfei An, PhD, Ritu Pandey, PhD, Neha Singh, PhD, Jin H Song, PhD, Jon C. Aster, MD PhD, Xue-Zhong Yu, PhD, Shikhar Mehrotra, PhD, Andrew S Kraft, MD
Journal: Blood
Blood (2016) 128 (22): 2742.
https://doi.org/10.1182/blood.V128.22.2742.2742
Published: 2016
Journal Articles

Dual Inhibition of mTOR and Pim Kinase Pathways Using Small Molecule Inhibitors Synergistically Kills Myeloid Leukemic Cells In Vitro and In Vivo.

Yingwei Lin, MD., PhD., Amanda M Graham, MS., Luciano J Costa, MD., PhD., Zanna M Beharry, PhD., Michael S Rosol, PhD., Zuping Xia, PhD., Baby Tholanikunnel, PhD, Robert K Stuart, MD., Andrew S Kraft, MD
Journal: Blood
Blood (2010) 116 (21): 293.
https://doi.org/10.1182/blood.V116.21.293.293
Published: 2010
Journal Articles

Phosphorylation of AML1 (RUNX1) Controls Transcription, Nuclear Localization, and Is Regulated during DNA Damage.

Suiquan Wang, PhD, Youhong Zhang, PhD, Joseph R. Biggs, PhD, Dong-Er Zhang, PhD, Andrew S. Kraft, MD
Journal: Blood
Blood (2005) 106 (11): 2712.
https://doi.org/10.1182/blood.V106.11.2712.2712
Published: 2005
Journal Articles

Cyclin-Dependent Kinases Phosphorylate AML1 (RUNX1) and Regulate AML1 Transactivation.

Joseph R. Biggs, PhD, Luke F. Peterson, PhD, Youhong Zhang, PhD, Andrew S. Kraft, MD, Dong-Er Zhang, PhD
Journal: Blood
Blood (2005) 106 (11): 2721.
https://doi.org/10.1182/blood.V106.11.2721.2721
Published: 2005